Selection bias clouds apparent benefit of longer hormone duration.
Kevin
K
Lin
Steve P
SP
Lee
Michael L
ML
Steinberg
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D017273:Goserelin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D015983:Selection Bias; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin